Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03975829
Title Pediatric Long-Term Follow-up and Rollover Study
Recruitment Recruiting
Gender both
Phase FDA approved
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications

childhood oligodendroglioma

malignant astrocytoma

oligodendroglioma

third ventricle chordoid glioma

pleomorphic xanthoastrocytoma

pilocytic astrocytoma

central neurocytoma

ganglioglioma

glioblastoma

gangliocytoma

cerebellar liponeurocytoma

Therapies

Dabrafenib + Trametinib

Age Groups: senior | adult | child
Covered Countries USA | FRA | ESP | CAN


No variant requirements are available.